Brief group education program for adults with ADHD
Official title: The Effect of a Brief Educational Intervention for Adults With ADHD: a Randomized Control Trial
Run by St. Olavs Hospital · NCT06284655 · Data updated 2026-11-12
This project will test whether a short group education program added to usual care helps adults with ADHD feel more confident, better informed, and more satisfied with their treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | St. Olavs Hospital Academic / other |
| Locations | 1 site (Trondheim) |
| Status | Recruiting |
| Started | February 14, 2025 |
| Main results expected | January 2027 |
| Study ends | December 2030 |
| Registry record updated | July 20, 2026 |
| Trial ID | NCT06284655 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a confirmed ADHD diagnosis who speak a Scandinavian language, are treated as outpatients at participating CMHCs, and are willing and able to give informed consent.
✕Probably not a fit
People who cannot give informed consent, are currently admitted to acute psychiatric wards, have severe learning difficulties, do not speak a Scandinavian language, or are enrolled in other research may not receive benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial compares a brief, group-based educational intervention co-developed with user representatives plus standard outpatient care to standard care alone for adults with ADHD in community mental health centres. The intervention combines group sessions and digital support tools and is delivered at participating CMHCs (led from St. Olav's Hospital) to outpatients who speak a Scandinavian language. Primary outcomes include patient satisfaction with treatment and information, general self-efficacy, and patient activation, analyzed using an intention-to-treat approach. Eligible participants have a confirmed ADHD diagnosis and are able to give informed consent, while those with severe learning difficulties or currently admitted to acute inpatient wards are excluded.
Why it matters
Potential benefit: If successful, the program could increase patient engagement, self-efficacy, and satisfaction with care, helping people manage ADHD more effectively within routine outpatient services.
How similar studies have gone: Educational and self-management programs have shown moderate benefits for patient satisfaction and activation in other mental health settings, but brief group psychoeducation specifically tailored for adults with ADHD remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirmed ADHD-diagnosis * Speaking a Scandinavian language * Willing to participate Exclusion Criteria: * Unable to give informed consent * In-patient on a acute psychiatric ward * Severe learning difficulties * Involvement in other research studies
Where it's running
-
St Olav's Hospital
Trondheim, Norway Recruiting
Study contacts
- Principal investigator: Mariela Loreto Lara-Cabrera, PhD — Norwegian University of Science and Technology
- Study coordinator: Mariela Loreto Lara-Cabrera, PhD
- Email: mariela.lara@ntnu.no
- Phone: +4748280188
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biomarkers that predict medication-related side effects in children with ADHD
This study tests whether combined brain, cognitive, and metabolite markers can predict side effects from methylphenidate in kids with ADHD.
-
Group CBT vs. Activity Group for Adults with ADHD
This trial tests whether group cognitive behavioral therapy helps adults with ADHD more than a structured activity group.
-
Central Executive Training and Behavioral Parent Training for Young Children with ADHD
This study tests Central Executive Training (CET) alone and CET combined with Behavioral Parent Training (BPT) to help young children with ADHD.
-
Solriamfetol for ADHD in teens: see if it helps with focus
This phase 3 study tests solriamfetol versus placebo in adolescents with ADHD to see if the medication improves symptoms over 6 weeks.
-
Solriamfetol for children with ADHD: a 6-week comparison to placebo
This trial tests whether solriamfetol can help children aged 6 to under 12 with ADHD, compared to placebo, over six weeks.
-
Impact of Sleep Timing and Duration on Teens with ADHD
This study tests how changing how long and when teens with ADHD sleep affects their attention and daily functioning.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.